FDA
-
-
-
-
-
-
-
Moderna names Juan Andres as COO amid oncology expansion
-
-
-
-
-
-
-
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
-
-
-
-
-
-
-
Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Moderna (MRNA) call put ratio 14 calls to 1 put with a focus on May 22 weekly 52, 55 and 57 calls
-
-
-
-
-
-
-
Moderna presents melanoma therapy data showing 83% response rate
-
-
-
-
-
-
-
Moderna (MRNA) PT Raised to $30 at RBC Capital
-
-
-
-
-
-
-
Moderna raises 2025 revenue forecast to $1.9 billion
-
335,145 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


